我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

充血性心力衰竭心肌β受体变化机理及其阻滞剂的应用(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
1997年第2期
页码:
88-90
栏目:
综述
出版日期:
1997-03-01

文章信息/Info

Title:
-
作者:
左文广 综述　侯应龙 审校
陕西省宝鸡市66信箱医院　宝鸡 721006
Author(s):
-
关键词:
心力衰竭;  充血性　细胞膜受体;  β 受体阻断剂
Keywords:
-
分类号:
-
DOI:
-
文献标识码:
-
摘要:
-
Abstract:
-

参考文献/References

［1］Bristow MR, Ginsburg R,Umans V , et al. β1-and β-Adrenergic receptor subpopulation in nonfailing and failing human ventricular-myocardium:Coupling of both receptor subtypes to muscle contraction and select ive β1-receptor down-regulation in heart failure. Circ Res, 1986; 59: 297.

［2］ Fowler MB, Laser JA , Hopkins GL , et al. Assessment of the β-adrenergic receptor pathway in the intract failing human heart: Progressive receptor down-regulation and subsensitivity to agonist receptor. Circulation, 1986; 74: 1290.

［3］Denniss AR, Marsh JD, Quigg RJ , et al. β-Adrenergic receptor member and adenylate cyclase function in denervanted transplanted and cardiomyopathic human heart. Circulation,1989; 79: 1028.

［4］ 郝玉明, 李星海.心力衰竭的β受体功能改变.心血管病学进展, 1994; 15 (5) : 272.

［5］Lefkowitx RJ , Garon MG, Stiles GL , et al.Mechanism of membrane-receptor regulation-biochemical, physiological and clinical insights derived from studies of adrenergic receptors. N Engl J Med , 1984; 314(24) : 1570.

［6］ Mann DL , Kent RL , Parsons B, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation, 1992; 85: 790.

［7］ Reichendach DD, Bendilt EP. Catecholamines and cardiomyopathy: The pathogenesis and potential importance of myofibrillar degeneration.Hum Pathol, 1979; 1: 125.

［8］ Limas CJ , Limas C, Kubo SH. Anti-Beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol, 1990; 65 (7) : 483.

[9]Bristow MR. Down-regulation of β-adrenergic receptor and receptor mRNA in heart cell chronically exposed to norepinephrine. Clin Res,1991; 39: 256A.

[10]Ungerer M , Bohm M , Elce JS, et al. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptor in the failing human heart.Circulation, 1993; 87 (2) : 454.

[11] Wuagestein F, Bristow MR, Swedberg K, et al.Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet, 1993; 342: 1441.

[12]彭　玲.β受体阻滞剂与心力衰竭.心血管病学进展, 1994; 15 (3) : 153.

[13]王荣兰, 郝金霞.β阻滞剂长期治疗特发性扩张型或缺血性心肌病心力衰竭的效果之剂量依赖性.国外医学心血管分册, 1995; 1: 22.

[14] Brutsaert DL. Nonuniformity: A physiologic modulator of contraction and relaxation of the normal heart. J Am CollCardiol, 1987; 9: 341.

[15] Wisenbaugh T , Katz I,Daris J , et al. Long-term(3 months) effects of a new β-blocker (nebivolol)on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol, 1993; 21: 1094.

[16]方 圻, 王士雯, 宁田海, 等.充血性心衰诊断和治疗对策.中华心血管病杂志, 1995; 4: 23.

备注/Memo

备注/Memo:
收稿 1996-02-27；修回 1996-12-09
更新日期/Last Update: 1997-03-01